News24.com | Covid-19: Third dose of Pfizer/BioNTech vaccine '95.6% effective'

A third dose of the vaccine against Covid-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to a study by the makers published on Thursday.